Low sodium oxybate for POTS in idiopathic hypersomnia
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study tests whether a low-sodium form of oxybate can reduce symptoms like dizziness, rapid heartbeat, and fatigue in people with both idiopathic hypersomnia and POTS. If you have these two conditions and haven't tried oxybate before, this trial may be a good fit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and speak English.
- You have been diagnosed with both idiopathic hypersomnia and POTS (postural tachycardia syndrome).
- You have never taken sodium oxybate or low sodium oxybate before.
- You have moderate to severe autonomic symptoms (like feeling dizzy, lightheaded, or having heart palpitations when standing).
- You are willing to use birth control if needed, and can keep your current medications stable during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether low-dose sodium oxybate can improve symptoms in adults with idiopathic hypersomnia, a condition that causes excessive sleepiness. You’d likely be asked to pause this standard treatment briefly while baseline testing is completed, and you’d use reliable contraception during and after the study drug.
This study looks at how narcolepsy or idiopathic hypersomnia affects thinking and cardiovascular health, and how usual treatment medications may change those outcomes. It may help researchers understand risks and benefits of common hypersomnia therapies.
This trial tests a new medication, HBS-301, in people with idiopathic hypersomnia (a condition causing excessive sleepiness without clear cause). It aims to see if the drug improves wakefulness and is safe.
This trial tests a new medicine called ALKS 2680 for people with Idiopathic Hypersomnia (a condition that causes extreme sleepiness without a clear cause). The goal is to see if it is safe and effective at helping you stay awake during the day.
This trial tests an experimental drug called ORX750 for people with narcolepsy or idiopathic hypersomnia. You would need to stop your current sleepiness medicines to see if ORX750 helps reduce daytime sleepiness.
This study tests whether a low dose of naltrexone can reduce symptoms in people with POTS, a condition where your heart rate rises too much when you stand. You may be asked to stay on your usual medications and attend study visits at specific Canadian cities.
Hear when a new Idiopathic Hypersomnia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.